Biora Therapeutics, Inc. (BIOR) Financial Ratios Annual - Discounting Cash Flows
BIOR
Biora Therapeutics, Inc.
BIOR (OTC)
Period Ending: LTM
(Last Twelve Months)
2023
12-31
2022
12-31
2021
12-31
2020
12-31
2019
12-31
2018
12-31
Price Ratios
Price to Earnings Ratio -0.003 -0.172 -0.659 -1.13 -1.54 -4.09 -2.74
Price to Sales Ratio 248.7 5,323 82.41 161.2 3.99 4.21 2.76
Price to Book Ratio -0.003 -0.21 -0.246 -2.36 -2.77 -7.22 -9.57
Price to Free Cash Flow Ratio -0.02 -0.438 -0.385 -1.19 -1.74 -5.51 -5.06
Price to Operating Cash Flow Ratio -0.007 -0.439 -0.39 -1.2 -1.79 -5.71 -5.43
Price Earnings to Growth Ratio 0.001 -0 0.008 0.024 -0.201 0.124 0
EV to EBITDA -1.33 -0.804 -2.04 -2.05 -3.43 -4.77 -3.26
Liquidity Ratios
Current Ratio 0.303 0.303 1.64 1.6 1.74 0.744 1.14
Quick Ratio 0.303 0.303 1.64 1.56 1.57 0.635 1.04
Cash Ratio 0.242 0.242 1.31 1.43 1.27 0.329 0.628
Debt Ratio 1.52 1.52 2.42 1.16 1.04 0.721 0.625
Debt to Equity Ratio -0.468 -0.468 -1.26 -1.49 -1.5 -0.875 -1.97
Long Term Debt to Capitalization -0.758 -0.758 5.01 3.05 3.01 -6.09 2.1
Total Debt to Capitalization -0.878 -0.878 4.79 3.05 3 -6.99 2.03
Interest Coverage Ratio -6.84 -6.84 -5.62 -9.33 -10.85 -15.23 -12.57
Cash Flow to Debt Ratio -1.02 -1.02 -0.498 -1.33 -1.03 -1.45 -0.895
Margins
Gross Profit Margin 100% 100% 100% 100% -25.73% 30.21% 28.05%
Operating Profit Margin -1,678,575% -1,678,575% -20,256% -9,450% -144.8% -97.31% -89.27%
Pretax Profit Margin -3,110,600% -3,110,600% -16,148% -14,326% -191.9% -103.3% -96.78%
Net Profit Margin -3,102,875% -3,102,875% -12,510% -14,316% -259.1% -102.8% -100.9%
Operating Cash Flow Margin -1,212,475% -1,212,475% -21,120% -13,431% -223% -73.7% -50.89%
Free Cash Flow Margin -1,215,050% -1,215,050% -21,380% -13,500% -229.7% -76.29% -54.67%
Return
Return on Assets -397.6% -397.6% -71.29% -164% -124.7% -145.5% -110.9%
Return on Equity 121.9% 122.4% 37.3% 210.1% 179.9% 176.5% 349.2%
Return on Capital Employed 211.4% 211.4% -204.4% -249.5% -131.6% -10,081% -298%
Return on Invested Capital 142.9% 142.9% 23,028% 286.1% 769.4% 440.6% 1,117%
Turnover Ratios
Receivables Turnover Ratio 0.005 0.005 0.368 1.91 11.2 6.31 15.71
Payables Turnover Ratio 0 0 0 0 5.38 6.38 8.34
Inventory Turnover Ratio 0 0 0 0 7.65 9.19 12.09
Fixed Asset Turnover Ratio 0.001 0.001 0.097 0.311 4.17 9.06 8.34
Asset Turnover Ratio 0 0 0.006 0.011 0.481 1.42 1.1
Per Share Items ()
Revenue Per Share 0.003 0.003 0.399 3.24 333.1 779.8 1,187
Operating Cash Flow Per Share -30.75 -30.75 -84.37 -435.5 -742.9 -574.7 -603.9
Free Cash Flow Per Share -30.81 -30.81 -85.41 -437.7 -765.1 -594.9 -648.7
Cash & Short Term Investments 9.64 9.64 39.93 229.8 412.7 178.9 641.7
Earnings Per Share -78.69 -78.69 -49.98 -464.2 -863 -801.7 -1,197
EBITDA Per Share -15.47 -42.22 -79.73 -302.6 -476 -733.9 -1,017
Dividend Per Share 0 0 0 0 0 24.37 0
Enterprise Value Per Share 20.64 33.92 162.3 621.3 1,634 3,498 3,313
Book Value Per Share -64.57 -64.3 -134 -220.9 -479.6 -454.2 -342.8
Price Per Share 0.221 13.5 32.92 522.5 1,328 3,280 3,280
Effective Tax Rate 0.072% 0.072% 0.853% 0.067% 26.32% 0.475% -4.24%
Short Term Coverage Ratio -24.54 -24.54 0 -13,957 -2,302 -440.3 -281.9
Capital Expenditure Coverage Ratio -470.9 -470.9 -81.33 -195.9 -33.52 -28.49 -13.48
EBIT Per Revenue -16,786 -16,786 -202.6 -94.5 -1.45 -0.973 -0.893
EBITDA Per Revenue -32.04 -16,647 -199.6 -93.34 -1.43 -0.941 -0.857
Days of Sales Outstanding 75,738 75,738 990.9 191.1 32.58 57.86 23.23
Days of Inventory Outstanding 0 0 0 0 47.73 39.72 30.19
Days of Payables Outstanding 0 0 0 0 67.89 57.22 43.74
Cash Conversion Cycle 75,738 75,738 990.9 191.1 12.43 40.36 9.68
Cash Conversion Ratio 0.391 0.391 1.69 0.938 0.861 0.717 0.504
Free Cash Flow to Earnings 0.392 0.392 1.71 0.943 0.887 0.742 0.542
discounting cash flows home logo

Discounting Cash Flows

Are you finding our services helpful? Review us on trustpilot logo Trustpilot
Have a question? Contact us
Want to become our sponsor?
Check out our Affiliate Program